Ownership history in Commodore Capital LP · 9 quarters on record
This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in APOGEE THERAPEUTICS INC (APGE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 290,000 | — | 0% | 0.56% | $11.5M | $39.73 |
| 2025 Q2 | UNCHANGED | 290,000 | — | 0% | 0.89% | $12.6M | $43.43 |
| 2025 Q1 | UNCHANGED | 290,000 | — | 0% | 0.80% | $10.8M | $37.36 |
| 2024 Q4 | UNCHANGED | 290,000 | — | 0% | 0.96% | $13.1M | $45.30 |
| 2024 Q3 | UNCHANGED | 290,000 | — | 0% | 1.06% | $17.0M | $58.74 |
| 2024 Q2 | UNCHANGED | 290,000 | — | 0% | 0.78% | $11.4M | $39.35 |
| 2024 Q1 | ADDED | 290,000 | +40,000 | +16.0% | 1.29% | $19.3M | $66.45 |
| 2023 Q4 | UNCHANGED | 250,000 | — | 0% | 0.60% | $7.0M | $27.94 |
| 2023 Q3 | INITIATED | 250,000 | — | — | 0.62% | $5.3M | — |
As of 2025 Q4 — sorted by position size